Injective Protocol (INJ) traded at $7.54 on October 2, 2026, rising 0.65% over the prior 24 hours. The token carries a market capitalization of $0.74 billion, placing it among the mid-tier digital assets by size.
Despite the daily uptick, INJ has shed 6.65% over the past seven days, pointing to selling pressure that has weighed on the token through the latter portion of the week. The near-term pullback stands in contrast to the broader momentum observed over a longer horizon.
Over the past 30 days, INJ has climbed 58.03%, a substantial gain that reflects a significant shift in market interest during that period. The monthly performance remains a notable data point even as shorter-term price action has turned softer.
The gap between the 30-day advance and the seven-day decline suggests the token has given back a portion of its recent gains but has not erased the bulk of the monthly move. Market capitalization of $0.74 billion reflects where INJ stands as of the current session.
